Bayer acquired Perfuse Therapeutics and its experimental endothelin-blocking eye implant PER-001, and partnered with AI firm Iambic Therapeutics to accelerate small molecule drug discovery.
|Articles|July 22, 2019
Study: Femtosecond laser-assisted arcuate incisions and plate-haptic toric IOLs
Author(s)Julianne Mobilian
ICYMI: Frank W. Bowden, III, MD, FACS shares the take-home message from his 2019 ASCRS presentation. Check it out below!
Advertisement
Frank W. Bowden, III, MD, FACS shares the take-home message from the presentation he delivered at the 2019 meeting of the
Advertisement
Related to this article
Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
Matching artificial tears to dry eye phenotype: a Q&A with Omur Ucakhan, MD
3
One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia
4
Women’s Health: Identifying dry eye in rheumatoid arthritis can make all the difference
5